ArticleCancers2021

The Survival Benefit of Chemoradiotherapy following Induction Chemotherapy with Gemcitabine Plus Nab-Paclitaxel for Unresectable Locally Advanced Pancreatic Cancer.

Ryoji Takada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.